Breakthrough Single-Cell Video Analysis Platform
By measuring up to three channels (voltage, Ca+ and contractility) of single-cell hiPSC kinetic data in real time and comparing cell response with known healthy or disease-model cells, Vala can help rank order drug candidates by identifying toxicities, dose response and efficacy.
Platform Enabled CRO Services
Vala delivers expert services that leverage our flagship Kinetic Image Cytometer (KIC®), CyteSeer® Cellular Analysis Algorithms and ValaDATE® AI Platform (in development).
Vala Sciences was founded in 2004 by Jeffrey Price, M.D., Ph.D. in San Diego. Dr. Price, a pioneer in high throughout cell imaging and data analysis, previously founded and led Q3DM until its acquisition by Beckman Coulter Inc. in 2003. Since its inception, Vala has worked closely with academic leaders, government health institutions and top pharmaceutical scientists to advance the state of cell imaging, analysis and interpretation for drug candidate screening.
Vala Sciences is privately held.